MTB by GeneXpert – Tissue at Dr. Essa Lab

MTB by GeneXpert – Tissue at Dr. Essa Lab

Tuberculosis (TB), caused by the bacterium Mycobacterium tuberculosis, remains one of the most significant public health challenges globally, particularly in developing nations like Pakistan. While pulmonary tuberculosis, which affects the lungs, is the most common manifestation, extrapulmonary tuberculosis (EPTB) presents a unique and formidable diagnostic challenge. Extrapulmonary tuberculosis can involve virtually any organ system, including the lymph nodes, pleura, peritoneum, bones, joints, central nervous system, and genitourinary tract. Diagnosing EPTB is notoriously difficult because tissue specimens from these sites are often paucibacillary, meaning they contain a very low concentration of bacterial cells. Traditional diagnostic modalities, such as Ziehl-Neelsen (ZN) smear microscopy, have extremely low sensitivity in tissue samples, often failing to detect the bacilli unless they are present in high numbers. Mycobacterial culture, while considered the gold standard, requires a prolonged incubation period of four to eight weeks, which significantly delays the initiation of life-saving anti-tuberculosis therapy (ATT). To address these clinical limitations, Dr. Essa Lab offers the MTB by GeneXpert – Tissue test, a state-of-the-art molecular diagnostic tool that provides rapid, highly sensitive, and specific detection of tuberculosis DNA directly from tissue specimens.

The GeneXpert MTB/RIF assay, developed by Cepheid, is an automated, cartridge-based nucleic acid amplification test (CBNAAT) that utilizes real-time Polymerase Chain Reaction (PCR) technology. This revolutionary system simultaneously detects the presence of Mycobacterium tuberculosis complex DNA and identifies mutations in the rpoB gene, which are strongly associated with resistance to rifampicin, a primary first-line anti-tuberculosis drug. Rifampicin resistance is a critical clinical indicator, serving as a reliable surrogate marker for multidrug-resistant tuberculosis (MDR-TB). By delivering highly accurate results in a matter of hours rather than weeks, the MTB by GeneXpert – Tissue test at Dr. Essa Lab enables clinicians to make rapid, evidence-based treatment decisions, significantly improving patient outcomes, reducing transmission rates, and preventing the progression of drug-resistant strains.

Clinical Procedure: What to Expect

Patient Preparation

Because the MTB by GeneXpert – Tissue test is performed on tissue specimens, patient preparation is primarily focused on the clinical or surgical procedure required to obtain the biopsy sample. Patients must closely follow the instructions provided by their referring surgeon, interventional radiologist, or gastroenterologist. Key preparation guidelines include:

• Consultation and Medical History: Inform your physician about all current medications, especially anticoagulants or antiplatelet agents such as aspirin, clopidogrel, warfarin, or novel oral anticoagulants (NOACs). These medications may need to be temporarily discontinued prior to the biopsy to minimize the risk of bleeding, under strict medical supervision.
• Fasting Requirements: If the tissue biopsy (such as a core needle biopsy, excision biopsy, laparoscopy, or endoscopy) is to be performed under local anesthesia with sedation or general anesthesia, you will typically be required to fast (nil by mouth) for six to eight hours before the procedure.
• Pre-Procedure Investigations: Your physician may request basic coagulation profiles (such as PT, APTT, and INR) and a complete blood count (CBC) to ensure it is safe to proceed with the tissue biopsy.
• Specimen Collection and Handling: The tissue specimen must be collected using strict aseptic techniques by a qualified clinician. It is absolutely critical that the collected tissue is placed immediately into a sterile container containing a few drops of sterile normal saline to keep it moist. The tissue must never be placed in formalin or any other chemical fixative. Formalin cross-links and degrades nucleic acids, which destroys the bacterial DNA and renders the sample completely unsuitable for PCR amplification, leading to invalid or false-negative results.

During the Procedure

The diagnostic process involves two main phases: the clinical collection of the tissue specimen and the subsequent molecular analysis at Dr. Essa Lab. During the collection phase, the patient is positioned comfortably depending on the biopsy site (e.g., lying flat for a lymph node biopsy or positioned for an ultrasound-guided core biopsy). The clinician sterilizes the skin, administers local anesthesia, and obtains the tissue sample using a biopsy needle or surgical excision. Once the specimen is secured in sterile saline, it is promptly transported to the molecular diagnostics department at Dr. Essa Lab.

At the laboratory, highly trained molecular technologists process the tissue specimen under strict biosafety conditions. The tissue is first homogenized using sterile tools to break down the cellular matrix and release any trapped mycobacteria. A specialized sample reagent is added to the homogenate; this reagent liquefies the sample and inactivates the vegetative bacteria, ensuring safety for the laboratory staff while preserving the bacterial DNA. After a brief incubation period, a specific volume of the treated sample is pipetted into a single-use GeneXpert cartridge. The cartridge is then loaded into the automated GeneXpert instrument. Inside the closed cartridge, the instrument automatically carries out cell lysis, genomic DNA extraction, PCR amplification, and real-time detection of the target sequences. The entire automated molecular assay is completed in approximately two hours, eliminating manual handling errors and minimizing the risk of cross-contamination.

When is a MTB by GeneXpert – Tissue Performed?

Suspected Extrapulmonary Tuberculosis

Physicians request this test when a patient presents with clinical symptoms suggestive of extrapulmonary tuberculosis. These symptoms often include persistent low-grade fever, unexplained weight loss, night sweats, chronic fatigue, and localized pain or swelling in non-pulmonary sites. Because extrapulmonary lesions are typically paucibacillary, traditional smear microscopy is highly unreliable. Performing a GeneXpert assay on the affected tissue provides the high sensitivity required to confirm or rule out active tuberculosis infection rapidly.

Evaluation of Persistent Lymphadenopathy

Tuberculous lymphadenitis, particularly involving the cervical lymph nodes, is a common presentation of extrapulmonary TB. When a patient presents with chronically enlarged, painless, or matted lymph nodes that do not respond to standard courses of broad-spectrum antibiotics, a biopsy is indicated. Testing the excised lymph node tissue or fine-needle aspirate with GeneXpert allows clinicians to rapidly differentiate tuberculosis from other causes of lymphadenopathy, such as lymphoma, metastatic malignancies, or reactive hyperplasia.

Assessment of Chronic Joint or Bone Pain

Skeletal tuberculosis, such as Pott’s disease (spinal tuberculosis) or tuberculous arthritis, can cause severe, irreversible joint destruction and neurological complications if left untreated. When patients present with chronic, localized bone or joint pain, limited range of motion, and radiological findings showing bone erosion or joint space narrowing, a biopsy of the bone or synovial tissue is performed. GeneXpert testing on these musculoskeletal tissue specimens offers rapid confirmation of mycobacterial infection, enabling early intervention to preserve joint function and spinal stability.

Investigation of Unexplained Pleural or Peritoneal Effusion

Pleural and peritoneal tuberculosis frequently lead to fluid accumulation in the pleural cavity (pleural effusion) or abdominal cavity (ascites). While fluid analysis is a standard initial step, its diagnostic yield for smear and culture is often low. When fluid analysis remains inconclusive, a pleural or peritoneal biopsy is performed. Analyzing the biopsy tissue using GeneXpert significantly increases the diagnostic sensitivity, helping to establish a definitive diagnosis of tuberculous pleuritis or peritonitis and preventing unnecessary delays in treatment.

Suspected Drug-Resistant Tuberculosis (MDR-TB)

In regions like Pakistan, where drug-resistant tuberculosis is a major public health concern, rapid drug susceptibility testing is critical. Clinicians perform this test when a patient with suspected extrapulmonary TB has a history of previous incomplete TB treatment, is failing to respond to standard anti-tuberculosis therapy, or has been in close contact with a known case of multidrug-resistant TB. The GeneXpert assay’s ability to detect rifampicin resistance mutations directly from the tissue sample within hours is invaluable for designing appropriate second-line therapeutic regimens.

What Does a MTB by GeneXpert – Tissue Detect?

The MTB by GeneXpert – Tissue test is a highly sophisticated molecular assay designed to detect several critical clinical parameters. Specifically, the test detects and evaluates:

• Mycobacterium tuberculosis Complex DNA: Direct molecular evidence of the presence of the genetic material of the TB-causing bacteria.
• Rifampicin Resistance: Mutations in the 81-bp hotspot region of the rpoB gene, which indicates resistance to rifampicin.
• Rifampicin Sensitivity: The presence of the wild-type rpoB gene sequence, indicating that the bacteria are likely sensitive to rifampicin.
• Semi-Quantitative Bacterial Load: An estimation of the concentration of bacterial DNA in the sample, categorized as High, Medium, Low, or Very Low.
• Paucibacillary Infections: Low levels of bacterial DNA that would otherwise be missed by conventional smear microscopy.
• Extrapulmonary Lymph Node Involvement: Confirmation of tuberculous lymphadenitis in cervical, axillary, or mediastinal lymph node biopsies.
• Skeletal Tuberculosis: Detection of mycobacterial DNA in bone biopsies or synovial tissue from patients with suspected Pott’s disease or tuberculous arthritis.
• Gastrointestinal Tuberculosis: Identification of TB DNA in bowel tissue biopsies obtained during colonoscopy or laparoscopy.
• Peritoneal Tuberculosis: Detection of mycobacterial involvement in peritoneal biopsy specimens.
• Pleural Tuberculosis: Confirmation of tuberculous pleurisy in pleural biopsy samples.
• Cutaneous Tuberculosis: Detection of TB DNA in skin biopsy specimens from atypical dermatological lesions.
• Genitourinary Tuberculosis: Identification of mycobacterial DNA in endometrial or testicular biopsies.
• Meningeal Tuberculosis: Detection of TB DNA in meningeal tissue biopsies (where applicable).
• Presence of PCR Inhibitors: Internal quality controls monitor the sample for substances that might interfere with the PCR reaction.
• Specimen Adequacy: Ensuring that the tissue sample was processed correctly and contains sufficient material for amplification.
• Indeterminate Drug Resistance: Situations where the bacterial load is too low to confidently determine the presence or absence of rifampicin resistance mutations.
• Active vs. Latent Infection Context: In the presence of clinical symptoms and histopathological granulomas, a positive result confirms active disease.
• Exclusion of Non-Tuberculous Mycobacteria (NTM): The test specifically targets the Mycobacterium tuberculosis complex, helping to differentiate it from other environmental mycobacteria.
• Rapid Diagnostic Confirmation: Eliminates the 4-to-8-week wait time associated with traditional mycobacterial cultures.
• Surrogate Marker for Multidrug Resistance: Since rifampicin resistance highly correlates with isoniazid resistance, it serves as an early warning for MDR-TB.

Turnaround Time and Report Access at Dr. Essa Lab

Dr. Essa Lab is committed to providing rapid and highly accurate diagnostic services to facilitate timely clinical decisions. For the MTB by GeneXpert – Tissue test, the turnaround time is typically 24 to 48 hours from the time the tissue specimen is received at the molecular diagnostics laboratory. This rapid processing is essential for patients with severe or rapidly progressing extrapulmonary tuberculosis, where early treatment is critical to prevent complications.

Once the analysis is complete, the report undergoes a rigorous multi-tier review by qualified molecular biologists and consultant pathologists. Dr. Essa Lab offers seamless access to diagnostic reports. Patients and healthcare providers receive an SMS notification with a secure link to download the PDF report. Reports can also be accessed and downloaded directly from the official Dr. Essa Lab web portal or mobile application. Physical copies of the reports can be collected from any of the numerous Dr. Essa Lab collection centers located across Karachi and other major cities in Pakistan.

MTB by GeneXpert – Tissue Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Mycobacterium tuberculosis DNA	Not Detected	Detected (categorized as High, Medium, Low, or Very Low bacterial load)
Rifampicin Resistance	Not Detected (Rifampicin Sensitive)	Detected (Rifampicin Resistant) or Indeterminate (due to low bacterial load)
Specimen Quality / PCR Control	Valid (Internal control amplification passed)	Invalid, Error, or No Result (indicates presence of PCR inhibitors or technical issues)
Lymph Node Tissue	Normal lymphoid architecture; negative for MTB DNA	Caseating granulomatous lymphadenitis; positive for MTB DNA
Synovial / Bone Tissue	Normal bone and joint structures; negative for MTB DNA	Granulomatous osteomyelitis or synovitis; positive for MTB DNA
Pleural / Peritoneal Tissue	Normal serosal tissue; negative for MTB DNA	Chronic granulomatous pleuritis or peritonitis; positive for MTB DNA
Gastrointestinal Tissue	Normal mucosal and submucosal tissue; negative for MTB DNA	Chronic granulomatous enteritis with caseation; positive for MTB DNA

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Dr. Essa Lab for MTB by GeneXpert – Tissue?

• Experienced Healthcare Professionals: Dr. Essa Lab features a team of highly qualified consultant pathologists, microbiologists, and molecular biologists who oversee all diagnostic procedures.
• Patient-Focused Care: The laboratory is dedicated to providing compassionate, accurate, and timely diagnostic services to support patient recovery.
• Quality Diagnostic Services: Adherence to strict international quality control standards ensures the highest level of diagnostic accuracy.
• Professional Reporting: Comprehensive, easy-to-understand reports that provide clear clinical insights for referring physicians.
• Modern Diagnostic Approach: Utilizing state-of-the-art molecular platforms, including Cepheid GeneXpert technology, for rapid nucleic acid amplification.
• Comfortable Environment: All collection centers and diagnostic facilities are designed to provide a clean, safe, and comfortable experience for patients.
• Convenient Location: An extensive network of diagnostic centers and collection points across Karachi and other major cities in Pakistan.
• Commitment to Accurate Diagnosis: A trusted name in healthcare diagnostics since 1987, committed to clinical excellence and ethical practices.